Veterinary Stents - Global Strategic Business Report

The global market for Veterinary Stents was estimated at US$52.2 Million in 2024 and is projected to reach US$75.7 Million by 2030, growing at a CAGR of 6.4% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Veterinary Stents market.

Global Veterinary Stents Market - Key Trends & Drivers Summarized

Why Are Veterinary Stents Becoming Essential in Animal Healthcare?

Veterinary stents have emerged as a vital tool in treating a wide range of conditions, including tracheal collapse, urethral obstruction, cardiovascular anomalies, and biliary duct obstructions in animals. As veterinary medicine advances, stent placement has become a minimally invasive alternative to traditional surgical interventions, providing long-term relief for conditions that previously required extensive and high-risk procedures. Tracheal collapse, particularly common in small dog breeds such as Yorkshire Terriers and Pomeranians, has been a significant driver for the adoption of stents, as they provide immediate airway support and improve breathing. Similarly, urethral and biliary stents have transformed the treatment of obstructive diseases in both companion animals and livestock, allowing for prolonged patency of blocked passages. Veterinary cardiology has also benefited from stenting procedures, particularly in treating congenital heart defects such as pulmonic stenosis. With the growing emphasis on minimally invasive techniques that reduce recovery times and procedural risks, veterinary stents are playing an increasingly important role in modern animal healthcare, offering improved quality of life for animals suffering from complex medical conditions.

What Are the Latest Advancements in Veterinary Stent Technology?

The veterinary stents market has seen significant technological advancements, enhancing the safety, durability, and efficacy of these devices. One of the most notable innovations is the development of self-expanding nitinol stents, which conform to anatomical structures without requiring surgical intervention. These stents provide superior flexibility, reducing the risk of migration and minimizing complications associated with rigid stents. Biodegradable stents are also emerging as a promising alternative, particularly for temporary interventions where long-term stenting may not be necessary. Additionally, advancements in drug-eluting stents, which slowly release medication to prevent inflammation and restenosis, are improving post-procedural outcomes. Custom-designed stents tailored to specific animal anatomies are gaining traction, particularly for tracheal and urethral applications, ensuring a better fit and reducing discomfort. The use of fluoroscopic and endoscopic guidance for stent placement has further improved precision, allowing veterinarians to position stents with minimal invasiveness. As research in biomaterials and veterinary interventional radiology continues to evolve, the effectiveness and versatility of stents in veterinary applications are expected to expand significantly.

What Challenges Are Hindering the Widespread Adoption of Veterinary Stents?

Despite their proven efficacy, several challenges are limiting the widespread adoption of veterinary stents. One of the primary barriers is the high cost associated with stent placement procedures, including the stent itself, specialized imaging equipment, and the expertise required for proper insertion. Many veterinary clinics and hospitals lack the necessary interventional radiology infrastructure, restricting access to stenting procedures to only well-equipped specialty centers. Additionally, while stents offer immediate relief for obstructive conditions, long-term complications such as stent migration, occlusion, and tissue in-growth remain concerns that require continuous monitoring and, in some cases, additional interventions. Another challenge is the lack of standardized veterinary stent sizes, as most stents used in animals are adaptations of human stents, which may not always provide an ideal anatomical fit. The learning curve associated with stenting procedures also limits adoption, as specialized training is required to ensure successful placement and post-operative management. Addressing these challenges will require further research into veterinary-specific stent designs, increased training opportunities for veterinarians, and broader availability of interventional radiology services in veterinary hospitals.

What Are the Key Growth Drivers of the Veterinary Stents Market?

The growth in the veterinary stents market is driven by several factors, including advancements in interventional veterinary medicine, increasing pet ownership, and the rising demand for minimally invasive treatment options. As more pet owners seek advanced medical care for their animals, there is growing interest in non-surgical solutions that offer shorter recovery times and improved outcomes. The expanding field of veterinary cardiology and pulmonology has significantly contributed to the demand for tracheal and vascular stents, particularly for treating congenital and age-related conditions. Additionally, the rising prevalence of urinary tract diseases and obstructions in both companion animals and livestock has fueled the need for urethral and biliary stents. Technological innovations in imaging and stent materials have also made these procedures safer and more effective, further driving market adoption. The increasing number of veterinary specialty hospitals equipped with interventional radiology facilities is making stent placement more accessible, expanding treatment options for a wider range of patients. As veterinary medicine continues to shift toward less invasive and more patient-friendly treatment methods, the veterinary stents market is expected to experience substantial growth, with continuous improvements in stent design and procedural techniques enhancing long-term success rates.

Scope of Study:

The report analyzes the Veterinary Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

• Segments: Product (Airway Stents, Urethral Stents, Vascular Stents, Other Stents); Animal Type (Dogs, Cats, Others); Material (Nitinol, Biodegradable Polymer); Application (Airway Collapse, Urinary Tract Obstructions, Vascular Obstructions, Other Applications); End-Use (Veterinary Hospitals & Clinics, Others)
• Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Airway Stents segment, which is expected to reach US$39.0 Million by 2030 with a CAGR of a 7.9%. The Urethral Stents segment is also set to grow at 4.4% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $13.7 Million in 2024, and China, forecasted to grow at an impressive 6.2% CAGR to reach $12.1 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Veterinary Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Veterinary Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Veterinary Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as AccuPath Group Co., Ltd., AbtVet (Stening Group), Alibaba Group Holding Ltd., Arthrex Vet Systems, Create Medic Co., Ltd. and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 39 companies featured in this Veterinary Stents market report include:

• AccuPath Group Co., Ltd.
• AbtVet (Stening Group)
• Alibaba Group Holding Ltd.
• Arthrex Vet Systems
• Create Medic Co., Ltd.
• Dextronix Animal Health
• Infiniti Medical
• M.I. Tech Co., Ltd.
• NuMED For Children
• TaeWoong Medical USA (VetSarang)
• UltraVet Medical Devices LLC
• VCA Animal Hospitals
• VetMedUSA
• VetStent
• Medtronic
• Boston Scientific
• Cook Medical
• Abbott Laboratories
• Terumo Corporation
• B. Braun Melsungen AG

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

• Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
• Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
• Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
• Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
• Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
• Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
• Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.